SION
NASDAQ · Biotechnology
Sionna Therapeutics Inc
$5.96
-1.22 (-16.99%)
Open$7.12
Previous Close$7.18
Day High$7.19
Day Low$5.90
52W High$54.97
52W Low$4.01
Volume—
Avg Volume1.34M
Market Cap326.78M
P/E Ratio—
EPS$-2.17
SectorBiotechnology
Analyst Ratings
Hold
17 analysts
Price Target
+320.5% upside
Current
$5.96
$5.96
Target
$25.06
$25.06
$14.18
$25.06 avg
$26.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 242.99M | 245.23M | 253.21M |
| Net Income | -48,406,908 | -45,232,819 | -47,387,261 |
| Profit Margin | -19.9% | -18.5% | -18.7% |
| EBITDA | -47,660,000 | -53,758,331 | -46,826,478 |
| Free Cash Flow | -27,352,313 | -27,764,891 | -38,614,891 |
| Rev Growth | +24.0% | +24.2% | +22.9% |
| Debt/Equity | 0.34 | 0.34 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |